New Study On Coronavirus

The research is based on an analysis of the data of more than 200,000 working-age adults from the Office for National Statistics (ONS) in the UK.

COVID-19: The Food Standards Agency (FSA) published research revealing how much time the Covid virus can survive on foods and food packaging.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

How lethal is Omicron? Does it cause a severe disease? Will a third dose of vaccine give better immunity? Scientists are racing to find the answers to these questions as Omicron cases soar across Europe and threaten year-end festivities.

Doctors in South Africa, where a new coronavirus variant of concern 'Omicron' has been found, have been studying symptoms of this new strain on COVID-19 patients and they have now made certain observations.

Relaxing restrictions like mask-wearing and social distancing when most people have been vaccinated greatly increases the risk of vaccine-resistant variants of the virus that causes Covid-19, new research showed on Friday.

The Gamaleya National Research Center of Epidemiology and Microbiology and RDIF on Monday announced strong results of the study on neutralizing the activity of sera from individuals vaccinated with Sputnik V vaccine against new coronavirus variants.

A new antibody testing study published Tuesday has found further evidence that the coronavirus was present in the United States from at least December 2019, weeks before the first confirmed case was announced on January 21, 2020.

The pandemic has shaken up the rankings of the world's most liveable cities, a study released on Wednesday showed, with metropolises in Australia, Japan and New Zealand leaping ahead of those in Europe.

Tests on mixing vaccines and the effectiveness of a single dose of Covishield will begin soon in the government's new strategy at a time the shortage of Covid shots has slowed down vaccinations.

A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.

The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.

Antibodies against the novel coronavirus wane at different rates, lasting for mere days in some individuals, while persisting in others for decades, according to a new study which says COVID-19 severity could be a deciding factor in having longer-lasting protection against reinfection.

The research is based on an analysis of the data of more than 200,000 working-age adults from the Office for National Statistics (ONS) in the UK.

COVID-19: The Food Standards Agency (FSA) published research revealing how much time the Covid virus can survive on foods and food packaging.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

How lethal is Omicron? Does it cause a severe disease? Will a third dose of vaccine give better immunity? Scientists are racing to find the answers to these questions as Omicron cases soar across Europe and threaten year-end festivities.

Doctors in South Africa, where a new coronavirus variant of concern 'Omicron' has been found, have been studying symptoms of this new strain on COVID-19 patients and they have now made certain observations.

Relaxing restrictions like mask-wearing and social distancing when most people have been vaccinated greatly increases the risk of vaccine-resistant variants of the virus that causes Covid-19, new research showed on Friday.

The Gamaleya National Research Center of Epidemiology and Microbiology and RDIF on Monday announced strong results of the study on neutralizing the activity of sera from individuals vaccinated with Sputnik V vaccine against new coronavirus variants.

A new antibody testing study published Tuesday has found further evidence that the coronavirus was present in the United States from at least December 2019, weeks before the first confirmed case was announced on January 21, 2020.

The pandemic has shaken up the rankings of the world's most liveable cities, a study released on Wednesday showed, with metropolises in Australia, Japan and New Zealand leaping ahead of those in Europe.

Tests on mixing vaccines and the effectiveness of a single dose of Covishield will begin soon in the government's new strategy at a time the shortage of Covid shots has slowed down vaccinations.

A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.

The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.

Antibodies against the novel coronavirus wane at different rates, lasting for mere days in some individuals, while persisting in others for decades, according to a new study which says COVID-19 severity could be a deciding factor in having longer-lasting protection against reinfection.